Ownership history in Graypoint LLC · 4 quarters on record
This page tracks every 13F SEC filing in which Graypoint LLC reported a position in ISHARES BIOTECHNOLOGY ETF (IBB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q1 | ADDED | 1,782 | +3 | +0.2% | 0.01% | $228K | $127.59 |
| 2024 Q4 | ADDED | 1,779 | +166 | +10.3% | 0.01% | $235K | $131.78 |
| 2024 Q3 | ADDED | 1,613 | +125 | +8.4% | 0.02% | $235K | $145.06 |
| 2024 Q2 | INITIATED | 1,488 | — | — | 0.01% | $204K | — |
As of 2025 Q4 — sorted by position size